MTSR - Metsera, Inc. Profit before interest, taxes and amortization

Brandmark of Metsera (MTSR)

EBITDA fluctuations correlate with the implementation of ESG standards in biopharmaceutical development and the greening of storage, with the metric reaching a value of 0.00. Metsera Inc bases its development of diabetes treatments in US centers, leveraging substantial capital. The continuity of clinical trials is ensured by the diversification of international suppliers of active pharmaceutical ingredients.

Metsera Corp - MTSR Operating profit EBITDA (period 11/23/2025 - 11/29/2025)

Summary analytical data breakdowns for Metsera (MTSR)

- current quotes and average value forecast:
Stock Quotes Metsera Therapeutics|MTSR - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Metsera|MTSR - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Metsera|MTSR - Book Capitalization|Market Capitalization to Book Value Ratio metsera.com|MTSR - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Metsera Inc|MTSR - Long-Term Debt to Equity|Current Liabilities to Capital Metsera, Inc.|MTSR - Company Debts|Debt to Book Capitalization Ratio Metsera|MTSR - Company Long-Term Debts|Short-Term Debt Volume Metsera|Interim Coverage Ratio metsera.com
- financial results and valuation multiples details:
MTSR - Company Net Income|Future Profit Metsera Inc|MTSR - Price to Earnings Ratio|Projected Price to Earnings metsera.com|MTSR - PEG Multiple|Company Value to EBITDA Metsera|MTSR - Operating profit before deduction of amortization|Earnings per share for the last four quarters Metsera|MTSR - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months metsera.com|MTSR - Earnings growth in current year|Expected net earnings per share growth next year Metsera Inc
Analysis of all company metrics:Metsera Therapeutics (MTSR)
Manufactured products of Metsera Inc

This indicator assesses business resilience to macroeconomic shocks by tracking the daily cash inflow from core operations before taxes and interest. For Metsera Inc (MTSR), whose focus is limited to the development of obesity drugs while maintaining basic environmental compliance, aggregated EBITDA serves as a measure of operational efficiency and management's ability to mitigate external risks, alerting investors to potential liquidity losses.

Who Metsera Inc competes with

ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MLTX (MoonLake Pharma) - Operating profit EBITDA|Operating profit EBITDA Crinetics Corp|Operating profit EBITDA NAMS|Profit before payment of interest, taxes and amortization SLNO (soleno.life)|Profit before payment of interest, taxes and amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Profit before interest, taxes and amortization|AGIO - Profit before payment of interest, taxes and amortization|GPCR: Profit before payment of interest, taxes and amortization|MDXG: Operating profit EBITDA|RZLT - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Profit before payment of interest, taxes and amortization Sagimet Biosciences SGMT|BIOA - Operating profit before deduction of amortization|Biomea Fusion - Operating profit EBITDA|Profit before interest, taxes and amortization Quince Therapeutics|GUTS (Fractyl) - Operating profit before deduction of amortization|VTVT: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Agape ATP Corp|Pluri Inc (PLUR) - Operating income before deduction of amortization|Operating profit EBITDA SYBX|LPCN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Matinas BioPharma Holdings MTNB|Income before deduction of interest, taxes and amortization SPRB|Galecto, Inc. - Operating profit EBITDA|CTCX - Operating profit EBITDA|LUMO (Lumos Pharma) - Operating profit before deduction of amortization|Organovo Holdings - Income before deduction of interest, taxes and amortization|RDUS (Radius Health) - Operating profit EBITDA